TY - JOUR
T1 - Quality of life in long-term survivors of ovarian germ cell tumors
T2 - A Gynecologic Oncology Group Study
AU - Champion, Victoria
AU - Williams, Stephen D.
AU - Miller, Anna
AU - Reuille, Kristina M.
AU - Wagler-Ziner, Kim
AU - Monahan, Patrick O.
AU - Zhao, Qianqian
AU - Gershenson, David
AU - Cella, David
N1 - Funding Information:
Supported by CAO82709 and CA 77470, NCI RO1 grant, Protocol GOG #9901.
PY - 2007/6
Y1 - 2007/6
N2 - Purpose: This report describes the strength and significance of the association between antecedent and mediating variables across four categories of quality of life (QOL) outcomes in 132 disease free women with ovarian germ cell survivors. Methods: Survivors (n = 132) participated in a mailed questionnaire and computer-assisted telephone survey. Participants in four prospective GOG protocols were contacted their treating physician for verbal consent to be approached by investigators at the Indiana University Cancer Center about a quality of life study. Similar patients treated at the MD Anderson Cancer Center were also included. If women verbally consented after being contacted by investigators at Indiana University, an informed consent and questionnaire packet was sent via mail. After return of the written informed consent and background questionnaire, a trained research assistant scheduled a computer-assisted interview to complete data collection. Results: Median follow-up from diagnosis was 10.2 years. Mediating variables of self-efficacy or social support played a significant role (p = 0.05 to p = 0.001) in all four QOL categories: physical functioning, psychological functioning, sexual functioning, and spiritual functioning. Being a younger age at diagnosis and married were positively related to sexual functioning (p = 0.05). Menstrual and gynecological symptoms were inversely related. Implications: Results indicate that clinicians may want to be especially sensitive to identifying a survivor's social support and confidence (self efficacy) in handling issues evolving from treatment since these skills may be related to overall quality of life outcomes.
AB - Purpose: This report describes the strength and significance of the association between antecedent and mediating variables across four categories of quality of life (QOL) outcomes in 132 disease free women with ovarian germ cell survivors. Methods: Survivors (n = 132) participated in a mailed questionnaire and computer-assisted telephone survey. Participants in four prospective GOG protocols were contacted their treating physician for verbal consent to be approached by investigators at the Indiana University Cancer Center about a quality of life study. Similar patients treated at the MD Anderson Cancer Center were also included. If women verbally consented after being contacted by investigators at Indiana University, an informed consent and questionnaire packet was sent via mail. After return of the written informed consent and background questionnaire, a trained research assistant scheduled a computer-assisted interview to complete data collection. Results: Median follow-up from diagnosis was 10.2 years. Mediating variables of self-efficacy or social support played a significant role (p = 0.05 to p = 0.001) in all four QOL categories: physical functioning, psychological functioning, sexual functioning, and spiritual functioning. Being a younger age at diagnosis and married were positively related to sexual functioning (p = 0.05). Menstrual and gynecological symptoms were inversely related. Implications: Results indicate that clinicians may want to be especially sensitive to identifying a survivor's social support and confidence (self efficacy) in handling issues evolving from treatment since these skills may be related to overall quality of life outcomes.
KW - Cancer survivorship
KW - Ovarian germ cell tumors
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=34248591386&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248591386&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2007.01.042
DO - 10.1016/j.ygyno.2007.01.042
M3 - Article
C2 - 17355890
AN - SCOPUS:34248591386
SN - 0090-8258
VL - 105
SP - 687
EP - 694
JO - Gynecologic oncology
JF - Gynecologic oncology
IS - 3
ER -